Permax Drug Pulled for Heart Valve Damage

Permax, the once popular drug for Parkinson’s Disease, has been pulled from the market by its manufacturer, Valeant Pharmaceuticals International. Permax has been linked to valvular heart damage in two recent studies and the FDA has asked the drug company to stop marketing the drug. According to FDA estimates, Permax is being used by 12,000-25,000 patients in the USA. If you or a loved one are taking Permax, please contact your doctor to inquire about alternative Parkinson’s treatments.